Targeting specific strains of the bacteria E.coli with vaccines or other treatments could help reduce the risk of bowel, bladder and prostate cancers, according to scientists.
It comes as a study suggested higher cases of certain cancers in industrialised countries such as the UK could be linked to two particular types of E.coli, which can cause infections in the urinary tract and bloodstream.
